Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]
Yin Q, Li J, Xia Y, Zhang R, et al. Drug Design, Development and Therapy. 2015;9:5407–5419. On page 5410, Figure 2 was wrongly labelled as Figure 3. On page 5410, the Notes for Figure 1 should be: + indicates low risk, - indicates high risk, and ? indicates this is unclear.&nb...
Saved in:
Main Authors: | Yin Q (Author), Li J (Author), Xia Y (Author), Zhang R (Author), Wang J (Author), Lu W (Author), Zhou Y (Author), Zheng Y (Author), Abudumijiti H (Author), Chen R (Author), Chen K (Author), Li S (Author), Liu T (Author), Wang F (Author), Lu J (Author), Guo C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
by: Yin Q, et al.
Published: (2015) -
Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis
by: Zhang Y, et al.
Published: (2015) -
Combination therapy of ursodeoxycholic acid and budesonide for PBC–AIH overlap syndrome: a meta-analysis
by: Zhang H, et al.
Published: (2015) -
Tubulointerstitial nephritis associated with primary biliary cirrhosis
by: Rasolzadegan Mohammad-Hosein, et al.
Published: (2014) -
Coadministration of Compound Danshen dripping pills and bezafibrate has a protective effect against diabetic retinopathy
by: Le Liu, et al.
Published: (2022)